In vitro time-dependent vancomycin-resistant Staphylococcus aureus-induced free radical generation and status of antioxidant enzymes in murine peritoneal macrophage

Toxicology Mechanisms and Methods

Volumn 22, Issue 1, 2012, Pages 9-22

  Chakraborty, Subhankari Prasad ^a   Mahapatra, Santanu Kar ^a   Roy, Somenath ^a  

^a VIDYASAGAR UNIVERSITY   (India)

Author keywords

Antioxidant enzyme; oxidative stress; peritoneal macrophage; VRSA

Indexed keywords

FREE RADICAL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; MYELOPEROXIDASE; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; VANCOMYCIN;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL SUSPENSION; COLONY FORMING UNIT; ENZYME ACTIVITY; IN VITRO STUDY; LIPID PEROXIDATION; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTIOXIDANTS; CATALASE; CELLS, CULTURED; FREE RADICALS; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDATION; MACROPHAGES, PERITONEAL; MALE; MICE; NADPH OXIDASE; NITRIC OXIDE; PEROXIDASE; PROTEIN CARBONYLATION; STAPHYLOCOCCUS AUREUS; SUPEROXIDE DISMUTASE; SUPEROXIDES; TIME FACTORS; VANCOMYCIN RESISTANCE;

EID: 83455249936     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2011.583296     Document Type: Article

References (51)

1. Ashakumary L, Vijayammal PL. 1996. Additive effect of alcohol and nicotine on lipid peroxidation and antioxidant defence mechanism in rats. J Appl Toxicol 16:305-308.
2. Azuma Y, Ohura K. 2001. Comparison of the effect of lidocaine- epinephrine and prilocaine-felypressine to alter macrophage functions. Int Immunopharmacol 1:911-923.
3. Babior BM, Lambeth JD, Nauseef W. 2002. The neutrophil NADPH oxidase. Arch Biochem Biophys 397:342-344.
4. Beaman L, Beaman BL. 1984. The role of oxygen and its derivatives in microbial pathogenesis and host defense. Annu Rev Microbiol 38:27-48.
5. Bos AR, Weaver R, Ross D. 1990. Characterization and quantification of the peroxidase in human neutrophils. Biochem Biophys Acta 525:4133-4141.
6. Bowersox J. 1999. Experimental staph vaccine broadly protective in animal studies. NIH 27:55-58.
7. Brouillette E, Grondin G, Shkreta L, Lacasse P, Talbot BG. 2003. In vivo and in vitro demonstration that Staphylococcus aureus is an intracellular pathogen in the presence or absence of fibronectinbinding proteins. Microb Pathog 35:159-168.
8. Chakraborty SP, Kar Mahapatra S, Sahu SK, Chattopadhyay S, Pramanik P, Roy S. 2011. Nitric oxide mediated Staphylococcus aureus pathogenesis and protective role of nanoconjugated vancomycin. Asian Pacific Journal of Tropical Biomedicine 1(2): 102-109.
9. Chakraborty SP, Kar Mahapatra S, Bal M, Roy S. 2010. Isolation and identification of vancomycin resistant Staphylococcus aureus from post operative pus sample. Al Ameen J Med Sci, 4(2):152-168.
10. Chance B, Sies H, Boveris A. 1979. Hydroperoxide metabolism in mammalian organs. Physiol Rev 59:527-605.
11. Das D, Saha SS, Bishayi B. 2008. Intracellular survival of Staphylococcus aureus: Correlating production of catalase and superoxide dismutase with levels of inflammatory cytokines. Inflamm Res 57:340-349.
12. Dawson JR, Vähäkangas K, Jernström B, Moldéus P. 1984. Glutathione conjugation by isolated lung cells and the isolated, perfused lung. Effect of extracellular glutathione. Eur J Biochem 138:439-443.
13. Dryla A, Gelbmann D, von Gabain A, Nagy E. 2003. Identification of a novel iron regulated staphylococcal surface protein with haptoglobin-haemoglobin binding activity. Mol Microbiol 49:37-53.
14. Gerster H. 1995. Beta-carotene, vitamin E and vitamin C in different stages of experimental carcinogenesis. Eur J Clin Nutr 49:155-168.
15. Griffith OW. 1980. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 106:207-212.
16. Habig WH, Pabst MJ, Jakoby WB. 1974. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130-7139.
17. Hassan HM, Fridovich I. 1978. Regulation of the synthesis of catalase and peroxidase in Escherichia coli. J Biol Chem 253:6445-6420.
18. Hattie DG, Jon HL, Tony EC, Bridget SW, Ambrose LC, Frederik PL. 2000. Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol 164:3713-3722.
19. Hemachand T, Gopalakrishnan B, Salunke DM, Totey SM, Shaha C. 2002. Sperm plasma-membrane-associated glutathione S-transferases as gamete recognition molecules. J Cell Sci 115:2053-2065.
20. Heyneman RA, Vercauteren RE. 1984. Activation of a NADPH oxidase from horse polymorphonuclear leukocytes in a cell-free system. J Leukoc Biol 36:751-759.
21. Ives TJ, Schwab UE, Ward ES, Hall IH. 2003. In-vitro anti-inflammatory and immunomodulatory effects of grepafloxacin in zymogen Aor Staphylococcus aureus-stimulated human THP-1 monocytes. J Infect Chemother 9:134-143.
22. Johnston RB Jr, Godzik CA, Cohn ZA. 1978. Increased superoxide anion production by immunologically activated and chemically elicited macrophages. J Exp Med 148:115-127.
23. Kar Mahapatra S, Chakraborty SP, Majumdar S, Bag BG, Roy S. 2009. Eugenol protects nicotine-induced superoxide mediated oxidative damage in murine peritoneal macrophages in vitro. Eur J Pharmacol 623:132-140.
24. Kar Mahapatra S, Das S, Bhattacharjee S, Gautam N, Majumdar S, Roy S. 2009. In vitro nicotine-induced oxidative stress in mice peritoneal macrophages: A dose-dependent approach. Toxicol Mech Methods 19:100-108.
25. Kirby WM. 1944. Extraction of a highly potent penicillin inactivator from penicillin resistant staphylococci. Science 99:452-453.
26. Kluytmans J, van Belkum A, Verbrugh H. 1997. Nasal carriage of Staphylococcus aureus: Epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10:505-520.
27. Levine RL, Williams JA, Stadtman ER, Shacter E. 1994. Carbonyl assays for determination of oxidatively modified proteins. Meth Enzymol 233:346-357.
28. Livermore DM. 2001. Antibiotic resistance in staphylococci. Int J Antimicrob Agents 16:3-10.
29. Lowy FD. 1998. Staphylococcus aureus infections. N Engl J Med 339:520-532.
30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
31. Luck H. 1963. Catalase. In Bergmeyer HW (Ed.), Methods of Enzymatic Analysis, Section 3. Academic Press, New York, pp. 885-894.
32. Mestro Del RF, McDonald W. 1986. Oxidative enzymes in tissue homogenates. In Greenwald RA (Ed.), CRC Handbook of Methods for Oxygen Radical Research. CRC Press, Boca Raton, FL, pp. 291-296.
33. Miwa S. 1972. Hematology. Mod Med Technol 3:306-310.
34. Moron MS, Depierre JW, Mannervik B. 1979. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 582:67-78.
35. Neu HC. 1992. The crisis in antibiotic resistance. Science 257:1064-1073.
36. Nordmann R, Rouach H. 1996. Free radical mechanisms and ethanol induced brain injury. In Deitrich RA, Erwin VG (Eds.), Pharmacological Effect of Ethanol on the Nervous System. CRC Press, Boca Raton, FL, pp. 329-341.
37. Ohkawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358.
38. Oliveros LB, Videla AM, Giménez MS. 2004. Effect of dietary fat saturation on lipid metabolism, arachidonic acid turnover and peritoneal macrophage oxidative stress in mice. Braz J Med Biol Res 37:311-320.
39. Paglia DE, Valentine WN. 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158-169.
40. Reznick AZ, Packer L. 1994. Oxidative damage to proteins: Spectrophotometric method for carbonyl assay. Meth Enzymol 233:357-363.
41. Sanai S, Tomisato M, Shinsuka N, Mayoko Y, Mayoko H, Akio N. 1998. Protective role of nitric oxide in S. aurues infection in mice. Infect Immunol 66:1017-1028.
42. Sandhu SK, Kaur G. 2002. Alterations in oxidative stress scavenger system in aging rat brain and lymphocytes. Biogerontology 3:161-173.
43. Sarkar S, Yadav P, Trivedi R, Bansal AK, Bhatnagar D. 1995. Cadmiuminduced lipid peroxidation and the status of the antioxidant system in rat tissues. J Trace Elem Med Biol 9:144-149.
44. Sievert DM, Boulton ML, Stoltman G, Johnson D, Stobierski MG, Downes FP. 2002. Staphylococcus aureus resistant to vancomycin- United States, 2002. Morb Mortal Wkly Rep 51:565-567.
45. Somani SM. 1996. Exercise, drugs and tissue specific antioxidant system. In Somani SM (Ed.), Pharmacology in Exercise and Sports. CRC Press, Boca Raton, FL, pp. 57-95.
46. Steigbigel RT, Lambert LH Jr, Remington JS. 1974. Phagocytic and bacterial properties of normal human monocytes. J Clin Invest 53:131-142.
47. Sullivan GW, Sarembock IJ, Linden J. 2000. The role of inflammation in vascular diseases. J Leukoc Biol 67:591-602.
48. Unanue ER. 1989. Macrophages, antigen-presenting cells, and the phenomena of antigen handling and presentation. In Paul WE (Ed.), Fundamental Immunology. Raven Press, New York, pp. 95-115.
49. van der Vaart H, Postma DS, Timens W, ten Hacken NH. 2004. Acute effects of cigarette smoke on inflammation and oxidative stress: A review. Thorax 59:713-721.
50. Vorobeva LI. 2004. Stressors, Stress reactions and survival of bacteria, a review. Appl Biochem Microbiol 40:261-269.
51. Wetscher GJ, Bagchi M, Bagchi D, Perdikis G, Hinder PR, Glaser K, Hinder RA. 1995. Free radical production in nicotine treated pancreatic tissue. Free Radic Biol Med 18:877-882.